Evidence map›Paper›PMID 41006834›Full record

ArticleNature microbiology2025

HIV infection reprogrammes CD4+ T cells for quiescence and entry into proviral latency.

Leah M Plasek Hegde, Lalith S Gunawardane, Farshad Niazi, Uri Mbonye, Konstantin Leskov, Gani Perez, Curtis Dobrowolski, Meenakshi Shukla, William S Nutt, Jonathan Karn and 1 more

Abstract read
In one paragraph

Article in Nature microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Leah M Plasek HegdeDepartment of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-0161-3277
Lalith S GunawardaneDepartment of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Farshad NiaziDepartment of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Uri MbonyeDepartment of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-7694-0803
Konstantin LeskovDepartment of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.ORCID http://orcid.org/0000-0001-6201-5660
Gani PerezDepartment of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-9133-6057
Curtis DobrowolskiDepartment of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Meenakshi ShuklaDepartment of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
William S NuttDepartment of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Jonathan KarnDepartment of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.ORCID http://orcid.org/0000-0002-2900-094X
Saba ValadkhanDepartment of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, OH, USA. saba.valadkhan@case.edu.ORCID http://orcid.org/0000-0002-6859-4883

Funding

WG3: HIV, Co-infections and Co-morbiditiesP30AI036219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI Immaculate Lillian Nankya · 1994 to 2026
$50.0M
Research Support Core D: Clinical and Behavioral ServicesP30DA054557 · NIDA · CASE WESTERN RESERVE UNIVERSITY · PI LEVINE, ALAN DAVID · 2021 to 2025
$16.2M
Control of P-TEFb biogenesis and HIV transcription in primary T-cellsR01AI148083 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI KARN, JONATHAN, MBONYE, URI · 2019 to 2023
$2.0M
Training Program in HIV CureT32AI127201 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI LEVINE, ALAN DAVID · 2016 to 2020
$919k
Role of non-coding RNA in establishing and maintaining HIV latencyR01AI120204 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI KARN, JONATHAN · 2015 to 2017
$594k
Defining the lncRNA-mediated cis regulatory networks that control HIV life cycle in T cellsR21AI127252 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI VALADKHAN, SABA · 2016 to 2017
$436k
NIAID NIH HHS P30 AI036219NIAID NIH HHS R01 AI120204NIAID NIH HHS R01 AI148083NIAID NIH HHS R21 AI127252NIAID NIH HHS T32 AI127201NIDA NIH HHS P30 DA054557
6 · The paper itself

Abstract

Human immunodeficiency virus (HIV) persists in infected individuals despite effective antiretroviral therapy due to the rapid establishment of latent reservoirs, mainly composed of quiescent memory CD4+ T cells. The mechanisms governing latent reservoir formation remain poorly understood. Here, using single-cell RNA-seq and functional studies in human primary CD4+ T cell models, we show that HIV infection with reporter constructs and laboratory and patient-derived strains triggers transcriptomic remodelling, activating the p53 pathway and a quiescence programme mediated by Krüppel-like factor 2 (KLF2), a key quiescence regulator. Loss- and gain-of-function studies, including unbiased shRNA screens and confirmatory studies in CD4+ T cells from HIV+ donors, demonstrate that HIV infection drives KLF2 and p53 signalling, which downregulate MYC and proliferation pathways, resulting in proviral transcriptional silencing. This enhances latent reservoir formation in T cells, ensuring viral persistence. These findings present a mechanism for forming the latent HIV reservoir and broaden the repertoire of strategies through which viruses control host cells to their advantage.

Indexed as

CD4-Positive T-LymphocytesHIV-1HIV InfectionsProvirusesVirus LatencyHumansKruppel-Like Transcription FactorsSignal TransductionSingle-Cell AnalysisTumor Suppressor Protein p53Kruppel-Like Transcription FactorsTumor Suppressor Protein p53

Identifiers

PMID41006834
PMCPMC12488490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.